Showing 1831-1840 of 10617 results for "".
Alligator Serum Antibodies: New Therapeutic Avenues
https://reachmd.com/programs/clinicians-roundtable/alligator-serum-antibodies-new-therapeutic-avenues/2977/Surely the first question you’re asking yourself is, how does one extract blood from an alligator? Mark Merchant, PhD, associate professor of biochemistry at McNeese State University, is one researcher brave enough to tackle this arduous task. Exactly why would Dr. Merchant go this far to get aholdYour Peds Patients' Risk of Alcohol Abuse
https://reachmd.com/programs/clinicians-roundtable/your-peds-patients-risk-of-alcohol-abuse/2964/Using alcohol, the apparent drug of choice for adolescents in our society, is often considered a normative right of passage. In this segment, Dr. Vivian Faden, leader of the NIH National Institute on Alcohol Abuse and Alcoholism's Underage Drinking Initiative, talks with host Dr. Bill Rutenberg abouImpact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
https://reachmd.com/cme/ACC-2025-nsMRA-HF/impact-of-finerenone-on-egfr-slope-by-baseline-albuminuria-in-finearts-hf/35846/Dr. Finnian McCausland shares new data from ERA 2025 showing finerenone slows eGFR decline across albuminuria levels in patients with HFmrEF/HFpEF.Why Patients Delay Seeking an Early Diagnosis for Alzheimer’s Disease
https://reachmd.com/programs/alzheimers-disease-towards-early-detection/why-patients-delay-seeking-early-diagnosis-alzheimers-disease/8328/Dr. Matt Birnholz reports on a study revealing patient delays for seeking a diagnosis for dementia by at least a year.Guiding the Collective Voice of OB/GYN: Dr. Hal Lawrence, EVP and CEO of ACOG
https://reachmd.com/programs/advances-in-womens-health/dr-hal-lawrence-evp-and-ceo-acog/7489/Dr. Matt Birnholz welcomes Dr. Hal Lawrence, Executive Vice President and CEO of the American College of Obstetricians and Gynecologists, to the program. Dr. Lawrence describes the clinical and administrative experiences that helped prepare him to assume the chief executive leadership role for ACOGInfection or Inflammation? Addressing Antibiotic Stewardship in Wound Care
https://reachmd.com/programs/the-word-on-wound-care/infection-or-inflammation-addressing-antibiotic-stewardship-wound-care/7346/Chronic wounds, by definition, are wounds that fail to go through the normal phases of healing. Understanding how and why wounds become chronic is one of the key priorities for any clinician encountering them, but there is a lot of confusion surrounding the presence or absence of infection in the inPediatric Heart Transplantation: Ethical Questions
https://reachmd.com/programs/focus-on-heart-health/pediatric-heart-transplantation-ethical-questions/3655/Donation of the heart after asystole leads to questions about the point at which death is irreversible. Dr. Armand Antommaria, assistant professor in the division of pediatric inpatient medicine and an adjunct assistant professor in the division of medical ethics and humanities at the University ofAntibodies Derived from the 1918 Flu Pandemic: Still Potent?
https://reachmd.com/programs/clinicians-roundtable/antibodies-derived-from-the-1918-flu-pandemic-still-potent/3653/Ninety-plus years after the 1918 influenza pandemic, we are just beginning to understand the naturally occurring adaptive immunity of those who were in contact with this devastating virus. As researchers probe survivors of the flu pandemic, all of whom are approaching or have attained centenarian stWeight Bias
https://reachmd.com/programs/clinicians-roundtable/weight-bias/3562/Obesity is associated with multiple medical and psychological co-morbidities. An often under recognized problem is that of weight related stigmatization which can lead to unfair treatment, prejudice and discrimination. Are you guilty? Dr. Rebecca Puhl, director of research and anti-stigma initiatiLatest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
https://reachmd.com/programs/cme/latest-data-publication-on-quantifying-the-link-between-ttr-response-and-mortality-reduction/36589/Review data from the ATTRibute-CM study linking early, sustained serum TTR increases with improved survival in patients treated with acoramidis.